Kenneth Klischies

Consolidated Researcher Details:

Institute of Clinical Molecular Biology, University of Kiel
Kenneth Klischies
k.klischies [at]
+49 (0) 431 / 500 - 15 153

Why this profession?

During school I was looking for a profession allowing me to live out my fascination for natural sciences and to work together in a team with people from totally different scientific backgrounds. Medicine as a professional perspective came to my mind because I was excited about the idea, that the biological conditions inside our body and in our direct environment influences every single part of human life. I think that knowledge about the human biological system and its interactions with the environment helps us to make reasonable and sustainable decision to improve every ones daily life. Medical studies enable me to gain a broad knowledge of the human body and physiology that will help me to set medical observations in a proper context. However most important for my decision to strive a medical career was that medicine is a subject of applied science, teaching how to help patients, how to continuously improve diagnostics and medical treatment, how to identify challenges for human health and wellbeing and most important – how to cope with those challenges.

Why RTG Genes, Environment and Inflammation?

Since medical study do not include teaching of scientific methods to a depth that is delivered by studies of natural sciences, I was looking for a doctoral programme that is based on intensive networking between doctoral candidates in medicine and life sciences to learn scientific work in constant exchange with each other.
Thematically, I also like the idea that under consideration of environmental factors and epigenetic mechanisms, we could better assess the influence of certain genetic properties on development of inflammatory disease in patients, maybe contributing to more personalized medicine in the future. With research on inflammatory bowel disease and colorectal cancer, the RTG 1743 genes, environment and inflammation and the Institute of clinical molecular Biology (IKMB) provide the opportunity to do research on a pathologically diverse and complex group of diseases that cause heavy burden on human health and life quality.